Efficacy and Tolerability of Peginterferon α-2a and Peginterferon α-2b, Both plus Ribavirin, for Chronic Hepatitis C: A Meta-Analysis of Randomized Controlled Trials
Figure 4
The discontinuation rates and drugs modification of CHC patients who received the two regimens.
(a) The overall discontinuation rate
(b) The discontinuation rate of naïve CHC patients treated with the two types of peginterferons
(c) Peginterferon dose modification of CHC patients treated with the two types of peginterferons
(d) Ribavirin dose modification of CHC patients treated with the two types of peginterferons